bluuebunny/crossref_metadata_2025_split huggingface dataset:
Improvement in the PBF-LB/M processing of the Al-Si-Cu-Mg composition through the use of pre-alloyed powder
Authors: Martucci A , Gobber F , Aversa A , Manfredi D , Fino P , Lombardi M 
Published: March 2023

Abstract
Among the many additive manufacturing technologies for metals, Powder Bed Fusion-Laser Beam (PBF-LB\M) stands out for its capacity to produce complex-shaped functional parts. However, the PBF-LB\M materials portfolio is still limited and the research into new high-performance Al-based alloys is ongoing. The improved properties with the addition of 4 wt% Cu to the AlSi10Mg alloy have been previously investigated in the literature through the in situ alloying approach in which the starting powders of Cu and AlSi10Mg are mechanically mixed and directly processed. However, inhomogeneities of alloying elements were found in samples produced with mixed AlSi10Mg+4Cu powders. To overcome this detrimental problem, the use of pre-alloyed AlSI10Cu4Mg powder obtained via gas atomisation process could be a powerful solution. With the aim of demonstrating the beneficial effects of pre-alloyed AlSi10Cu4Mg powders in laser-powder interaction, preliminary SEM investigations were conducted on cross-sectioned SSTs and bulk samples after optimising the process parameters. The deeper microstructural investigations conducted on pre-alloyed AlSi10Cu4Mg samples revealed a higher homogeneity of alloying elements, a smaller cell size of the Al-Si-Cu network (0.5 versus 0.8 μm) and a slightly smaller mean diameter of equiaxial grains compared to the mixed AlSi10Mg+4Cu ones (6.01 versus 7.34 μm). In addition, looking closer at the supersaturation level and the precipitation behaviour in pre-alloyed AlSi10Cu4Mg composition, a high solid solution level, a massive presence of Al2Cu in the cell network and only a few finely dispersed Al2Cu precipitates within the cells were found. Exploring the benefits of these microstructural features on mechanical properties, an increase in performance of about 18% in micro-hardness tests and more than 10% in tensile and compressive tests were found in the AlSi10Cu4Mg system with respect to the mixed AlSi10Mg+4Cu system. All the thorough investigations proved how using pre-alloyed powders is an important advantage in the PBF-LB/M production of complex Al-based systems.
Molecular dynamics study on the structural properties and phase transformation of Cu-Au nanoparticles
Authors: Cui Haowei , Meng Kun 
Published: March 2023

Abstract
The electroreduction of CO2 to carbon-containing products carries considerable significance. Cu-Au alloys have been considered as potential bimetallic catalysts recently. However, the current theoretical study of obtaining Cu-Au alloys that could enhance the catalytic activity is insufficiently thorough. Herein, the structural properties and phase transition rules of Cu-Au nanoparticles are investigated utilizing molecular dynamics. The results indicate that the percentage of disordered atoms in Cu-Au nanoparticles decreases and the melting temperature increases with the growth of particle size. Moreover, the coordination number decreases with increasing radial distance. Cu-Au nanoparticles are coexisting in crystalline and amorphous states during melting. The structural properties of Cu-Au catalysts could be regulated by the phase transition rules, which provided a theoretical basis for the modification of surface activity.
Bridging with surgically placed microaxial left ventricular assist devices: a high-volume centre experience
Authors: Gill George , Rowe Georgina , Chen Qiudong , Malas Jad , Thomas Jason , Peiris Achille , Cole Robert , Chikwe Joanna , Megna Dominick , Emerson Dominic 
Published: March 2023

Abstract

OBJECTIVES
The Impella 5.0 and 5.5 have largely superseded non-ambulatory temporary mechanical support devices; yet, clinical outcomes are predominantly limited to small series: this study presents the experience of a high-volume centre.

METHODS
An institutional clinical registry was used to identify all patients with cardiogenic shock who underwent Impella 5.0 or 5.5 implantation from January 2014 to March 2022. The primary outcome was survival to device explantation.

RESULTS
The study cohort comprised 221 patients, including 146 (66.1%) Impella 5.0 and 75 (33.9%) Impella 5.5 patients. The primary aetiology was non-ischaemic cardiomyopathy (50.7%, n = 112), ischaemic cardiomyopathy (23.1%, n = 51) and acute myocardial infarction (26.2%, n = 58). Patients were prospectively classified according to strategy as bridge to transplant (47.5%, n = 105), bridge to durable device (13.6%, n = 30) or bridge to recovery (38.9%, n = 86). Patients were predominantly Interagency Registry for Mechanically Assisted Circulatory Support profile 1 or 2 (95.0%, n = 210). The median bridging duration was 14 (range 0–137) days. Device exchange, Ischaemic stroke and ipsilateral arm ischaemia occurred in 8.1% (n = 18), 2.7% (n = 6) and 1.8% (n = 4) of patients, respectively. Compared to the 75 most recent Impella 5.0 patients, Impella 5.5 patients (n = 75) had lower rates of device exchange (4.0%, n = 3 vs 13.3%, n = 10, P = 0.04). Overall, 70.1% (n = 155) of patients survived to Impella explantation.

CONCLUSIONS
The Impella 5.0 and 5.5 provide safe and effective temporary mechanical support in appropriately selected patients with cardiogenic shock. The newer device generation may have a lower requirement for device exchange as compared to its predecessor.
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?
Authors: Niculescu Dan Alexandru , Gheorghiu Monica Livia , Poiana Catalina 
Published: March 2023

AbstractRadiotherapy, conventional or radiosurgery, has been used to control prolactin secretion and tumour growth in prolactinomas both as part of multimodal therapy or rarely as primary treatment. However, considering the radiotherapy side effects, notably hypopituitarism, as opposed to the high efficacy and low toxicity of dopamine agonists (DA) treatment and neurosurgery, radiotherapy is recommended mostly for patients with aggressive or high-risk prolactinomas or in those resistant or intolerant to medical therapy, usually after surgical failure. We provide an overview of the published literature on the efficacy and toxicity of radiotherapy (conventional fractionated or radiosurgery), in aggressive, high-risk, or DA resistant prolactinomas. Radiotherapy has shown a good efficacy and a reasonable toxicity profile in prolactinomas where other treatment modalities failed. In aggressive and high-risk prolactinomas, the cumulative percentage for tumour control (reduction plus stable) ranged from 68% to 100%. Most studies reported global hormonal control rates over 50%. In resistant prolactinomas, the global secretion control rate (on, but also off DA) ranged from 28% to 89%–100%; in most studies over 80%. The 5-year rate of hypopituitarism was around 12%–25%. To date there are no controlled study on the use of radiotherapy as a prophylactic treatment in patients with clinical, radiological or pathological markers of aggressiveness. In conclusion, our review supports the use of radiotherapy in patients with growing, clinically aggressive or truly DA resistant prolactinomas. In patients with high-risk or invasive prolactinomas or in those harboring pathological markers of aggressiveness, the prophylactic use of radiotherapy should be individualized.
An exponential increase in QTL detection with an increased sample size
Authors: Chitre Apurva S , Polesskaya Oksana , Munro Daniel , Cheng Riyan , Mohammadi Pejman , Holl Katie , Gao Jianjun , Bimschleger Hannah , Martinez Angel Garcia , George Anthony M , Gileta Alexander F , Han Wenyan , Horvath Aidan , Hughson Alesa , Ishiwari Keita , King Christopher P , Lamparelli Alexander , Versaggi Cassandra L , Martin Connor D , St. Pierre Celine L , Tripi Jordan A , Richards Jerry B , Wang Tengfei , Chen Hao , Flagel Shelly B , Meyer Paul , Robinson Terry E , Solberg Woods Leah C , Palmer Abraham A 
Published: March 2023

Abstract
Power analyses are often used to determine the number of animals required for a genome-wide association study (GWAS). These analyses are typically intended to estimate the sample size needed for at least 1 locus to exceed a genome-wide significance threshold. A related question that is less commonly considered is the number of significant loci that will be discovered with a given sample size. We used simulations based on a real data set that consisted of 3,173 male and female adult N/NIH heterogeneous stock rats to explore the relationship between sample size and the number of significant loci discovered. Our simulations examined the number of loci identified in subsamples of the full data set. The subsampling analysis was conducted for 4 traits with low (0.15 ± 0.03), medium (0.31 ± 0.03 and 0.36 ± 0.03), and high (0.46 ± 0.03) SNP-based heritabilities. For each trait, we subsampled the data 100 times at different sample sizes (500, 1,000, 1,500, 2,000, and 2,500). We observed an exponential increase in the number of significant loci with larger sample sizes. Our results are consistent with similar observations in human GWAS and imply that future rodent GWAS should use sample sizes that are significantly larger than those needed to obtain a single significant result.
Stranding collections indicate broad-scale connectivity across the range of a pelagic marine predator, the Atlantic white-sided dolphin (Lagenorhynchus acutus)
Authors: Gose M-A , Humble E , Brownlow A , Mikkelsen B , Loftus C , Wall D , Rogan E , ten Doeschate M , Davison N , Ogden R 
Published: March 2023

Abstract
Understanding the extent of population genetic connectivity in highly mobile marine species is vital for delineating management units. However, obtaining samples for generating genetic data is challenging for species inhabiting inaccessible pelagic waters. As a result, management strategies do not always align with underlying population biology. Marine strandings provide an accessible and cost-effective sample source for research on elusive cetaceans and can be used collaboratively among stranding networks to generate ecosystem-wide population genetic assessments. Here, we used samples collected from strandings and free-ranging individuals across the North Atlantic to investigate population structure, genetic diversity, and individual relatedness in the Atlantic white-sided dolphin (AWSD; Lagenorhynchus acutus), a widely distributed marine predator. Mitochondrial DNA sequences and nuclear DNA single-nucleotide polymorphisms showed a complete lack of population differentiation across the species’ range, implying an unusual pattern of strong connectivity. No differences in genetic diversity among geographic regions and weak within-group relatedness further support the existence of species-wide panmixia in AWSD. This study emphasises the value of long-term stranding collections for cetacean research and has important implications for AWSD conservation management.
Cow’s milk alternatives for children with cow’s milk allergy and beyond
Authors: Williams Brock A , Erdle Stephanie C , Cochrane Kelsey M , Wingate Kirstin , Hildebrand Kyla J 
Published: March 2023

Abstract
Cow’s milk allergy (CMA) is one of the most common food allergies in the first years of life, with worldwide prevalence estimated to range from 2% to 5%. While the majority of children with CMA will eventually develop tolerance to cow’s milk proteins (it is estimated that &gt;75% of children with CMA develop tolerance to cow’s milk proteins by the age of 3 years, and &gt;90% develop tolerance by the age of 6 years), the selection of an appropriate cow’s milk (CM) alternative for those with CMA is vital to ensure adequate growth and development during childhood. The increasing number of CM alternative products on the commercial market with markedly different nutritional content and micronutrient fortification adds a layer of complexity that can be challenging for both families and clinicians to navigate. This article aims to provide guidance and clarity to Canadian paediatricians and primary care clinicians on recommending the most appropriate, safe, and nutritionally optimal CM alternatives for individuals with CMA, and beyond.
Inhibition of invasive plant Mikania micrantha rapid growth by host-specific rust (Puccinia spegazzinii)
Authors: Zhang Guangzhong , Wang Chenjiaozi , Ren Xinghai , Li Zaiyuan , Liu Conghui , Qiao Xi , Shen Shicai , Zhang Fudou , Wan Fanghao , Liu Bo , Qian Wanqiang 
Published: March 2023

Abstract
Mikania micrantha Kunth is a fast-growing global invasive weed species that causes severe damage to natural ecosystems and very large economic losses of forest and crop production. Although Puccinia spegazzinii can effectively inhibit the growth of M. micrantha and is used as a biological control strain in many countries, the mechanism of inhibiting the growth of M. micrantha is not clear. Here, we used a combination of phenotypic, enzyme activity, transcriptomic, and metabolomic approaches to study the response of M. micrantha after infection by P. spegazzinii. In the early stages of rust infection, jasmonic acid (JA), jasmonoyl-isoleucine (JA-Ile), and salicylic acid (SA) levels in infected leaves were significantly lower than those in uninfected leaves. In teliospore initial and developed stages of P. spegazzinii, JA and JA-Ile levels substantially increased by more than 6 times, which resulted in a significant decrease in the accumulation of defense hormone SA in infected leaves of M. micrantha. The contents of plant growth-promoting hormones were significantly reduced in the infected plants as a result of substantial downregulation of the expression of key genes related to hormone biosynthesis. Furthermore, rust infection led to high levels of reactive oxygen species in chloroplasts and the destruction of chlorophyll structure, which also led to decreased photosynthetic gene expression, net photosynthetic rate, activity of Rubisco, and levels of important organic acids in the Calvin cycle. We hypothesized that after P. spegazzinii infection, JA or JA-Ile accumulation not only inhibited SA levels to promote rust infection and development, but also impeded the rapid growth of M. micrantha by affecting plant growth hormones, carbon, and nitrogen metabolic pathways.
Survey of Buprenorphine Low-dose Regimens Used by Healthcare Institutions
Authors: Hardy Monika , Grable Samantha , Otley Rachel , Pershing Michelle 
Published: March 2023

Background
Buprenorphine microdosing (“low-dosing”) allows for initiation of buprenorphine without requiring patients to endure withdrawal. Case studies suggest its favorable utility as an alternative to conventional buprenorphine induction. However, published regimens vary in duration, dosage forms used, and timing of full opioid agonist discontinuation.

Methods
This cross-sectional survey study sought to determine how buprenorphine low-dosing is approached by medical institutions across the United States. The primary end point was characterization of inpatient buprenorphine low-dosing regimens. Situations and types of patients in which low-dosing is used and obstacles to institutional protocol development were also collected. An online survey was disseminated through professional pharmacy organizations and personal contacts. Responses were collected over 4 weeks.

Results
Twenty-three unique protocols were collected from 25 institutions. Most protocols used buccal (8 protocols) or transdermal (8 protocols) buprenorphine as first doses before transitioning to sublingual buprenorphine. The most common starting doses were buprenorphine 20 μg/h transdermal, 150 μg buccal, and 0.5 mg sublingual. Patients unable to tolerate conventional buprenorphine induction or those who potentially used fentanyl nonmedically were most likely to be prescribed low-dosing. The most common obstacle to developing an internal low-dosing protocol was lack of existing consensus guidelines.

Conclusions
Similar to published regimens, internal protocols are variable. Buccal first doses may be used more commonly in practice based on survey results, while transdermal first doses are more commonly reported in publications. More research is needed to determine whether differences in starting formulations impact safety and efficacy of buprenorphine low-dosing in the inpatient setting.
Duration and Quality of Sleep and Risk of Self-reported Hearing Loss: The UK Biobank Study
Authors: Yévenes-Briones Humberto , Caballero Francisco Félix , Estrada-deLeón Daniela B. , Struijk Ellen A. , Mesas Arthur Eumann , Banegas José R. , Rodríguez-Artalejo Fernando , Lopez-García Esther 
Published: March 2023

Objective:
The duration and quality of sleep have been associated with multiple health conditions in adults. However, whether sleep duration and quality are associated with hearing loss (HL) is uncertain. The present study investigates the prospective association between duration and quality of sleep and HL.

Design:
This longitudinal analysis included 231,650 participants aged 38 to 72 years from the UK Biobank cohort, established in 2006–2010 in the United Kingdom. Duration and sleep complaints (snoring at night, daytime sleepiness, sleeplessness, difficulty getting up in the morning, and eveningness preference) were self-reported. HL was self-reported at baseline and during the follow-up.

Results:
Over a median follow-up of 4.19 (SD: 2.15) years, 6436 participants reported incident HL. In fully adjusted models, in comparison with sleeping between 7 and 8 hours a day, the adjusted hazard ratio (HR) (95% CI) associated with sleeping <7 hours a day was 1.01 (0.95 to 1.07), and for sleeping >8 hours a day was 0.98 (0.88 to 1.08). After adjustment for potential confounders, the HRs (95% confidence interval) of HL associated with having 1, 2, 3, and 4 to 5 vs. 0 sleep complaints were: 1.15 (1.05 to 1.27), 1.16 (1.05 to 1.28), 1.32 (1.19 to 1.47), and 1.49 (1.31 to 1.69), respectively; p for trend: <0.001. An increase in the number of sleep complaints was associated with higher risk of HL among participants with non-optimal sleep duration than among participants with optimal sleep duration.

Conclusion:
In this large population-based study, poor sleep quality was associated with an increased risk of HL; however, sleep duration was not associated with risk.
Do They Have a Choice? Surrogate Decision-Making After Severe Acute Brain Injury*
Authors: Goss Adeline L. , Voumard Rachel Rutz , Engelberg Ruth A. , Curtis J. Randall , Creutzfeldt Claire J. 
Published: March 2023

Objectives:
In the early phase of severe acute brain injury (SABI), surrogate decision-makers must make treatment decisions in the face of prognostic uncertainty. Evidence-based strategies to communicate uncertainty and support decision-making are lacking. Our objective was to better understand surrogate experiences and needs during the period of active decision-making in SABI, to inform interventions to support SABI patients and families and improve clinician-surrogate communication.

Design:
We interviewed surrogate decision-makers during patients’ acute hospitalization for SABI, as part of a larger (n = 222) prospective longitudinal cohort study of patients with SABI and their family members. Constructivist grounded theory informed data collection and analysis.

Setting:
One U.S. academic medical center.

Patients:
We iteratively collected and analyzed semistructured interviews with 22 surrogates for 19 patients.

Interventions:
None.

Measurements and Main Results:
Through several rounds of coding, interview notes, reflexive memos, and group discussion, we developed a thematic model describing the relationship between surrogate perspectives on decision-making and surrogate experiences of prognostic uncertainty. Patients ranged from 20 to 79 years of age (mean = 55 years) and had primary diagnoses of stroke (n = 13; 68%), traumatic brain injury (n = 5; 26%), and anoxic brain injury after cardiac arrest (n = 1; 5%). Patients were predominantly male (n = 12; 63%), whereas surrogates were predominantly female (n = 13; 68%). Two distinct perspectives on decision-making emerged: one group of surrogates felt a clear sense of agency around decision-making, whereas the other group reported a more passive role in decision-making, such that they did not even perceive there being a decision to make. Surrogates in both groups identified prognostic uncertainty as the central challenge in SABI, but they managed it differently. Only surrogates who felt they were actively deciding described time-limited trials as helpful.

Conclusions:
In this qualitative study, not all surrogate “decision-makers” viewed themselves as making decisions. Nearly all struggled with prognostic uncertainty. Our findings underline the need for longitudinal prognostic communication strategies in SABI targeted at surrogates’ current perspectives on decision-making.
TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition
Authors: Song Hongxiao , Xiao Qingfei , Xu Fengchao , Wei Qi , Wang Fei , Tan Guangyun 
Published: March 2023

Abstract

Background:
The hepatitis B virus (HBV) vaccine has been efficiently used for decades. However, hepatocellular carcinoma caused by HBV is still prevalent globally. We previously reported that interferon (IFN)-induced tripartite motif-containing 25 (TRIM25) inhibited HBV replication by increasing the IFN expression, and this study aimed to further clarify the anti-HBV mechanism of TRIM25.

Methods:
The TRIM25-mediated degradation of hepatitis B virus X (HBx) protein was determined by detecting the expression of HBx in TRIM25-overexpressed or knocked-out HepG2 or HepG2-NTCP cells via Western blotting. Co-immunoprecipitation was performed to confirm the interaction between TRIM25 and HBx, and colocalization of TRIM25 and HBx was identified via immunofluorescence; HBV e-antigen and HBV surface antigen were qualified by using an enzyme-linked immunosorbent assay (ELISA) kit from Kehua Biotech. TRIM25 mRNA, pregenomic RNA (pgRNA), and HBV DNA were detected by quantitative real-time polymerase chain reaction. The retinoic acid-inducible gene I (RIG-I) and pgRNA interaction was verified by RNA-binding protein immunoprecipitation assay.

Results:
We found that TRIM25 promoted HBx degradation, and confirmed that TRIM25 could enhance the K90-site ubiquitination of HBx as well as promote HBx degradation by the proteasome pathway. Interestingly, apart from the Really Interesting New Gene (RING) domain, the SPRY domain of TRIM25 was also indispensable for HBx degradation. In addition, we found that the expression of TRIM25 increased the recognition of HBV pgRNA by interacting with RIG-I, which further increased the IFN production, and SPRY, but not the RING domain is critical in this process.

Conclusions:
The study found that TRIM25 interacted with HBx and promoted HBx-K90-site ubiquitination, which led to HBx degradation. On the other hand, TRIM25 may function as an adaptor, which enhanced the recognition of pgRNA by RIG-I, thereby further promoting IFN production. Our study can contribute to a better understanding of host-virus interaction.